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Systematic Study of Amyloid Beta Peptides: Implications for Alzheimer’s Disease

Jeffy Jiménez
ABSTRACT

The amyloid beta peptide particularly the 40 and 42 amino acid residues are the
responsible for plaque formation in Alzheimer's disease (AD) patients. Extra cellular
plaque formation has been recognized after incessant investigations along with the
formation of intracellular tau protein tangles as the hallmarks of AD. Furthermore, the
plaque formation has been linked mostly as a cause of the disease and the tangles mostly
as a consequence. Our investigation is focused on studying the formation of AD plaques.
The amyloid beta (Aß) is a physiological peptide secreted from neurons under normal
conditions, along with other soluble forms cleaved from the amyloid precursor protein
(APP). These soluble forms of APP have neuroprotective and neurotrophic functions,
while the Aß is considered an unwanted by-product of the APP processing. Under normal
conditions there is an anabolic/catabolic equilibrium of the Aß peptide; therefore, it is
believed that the formation of the plaque does not take place. On the other hand, the
neurons' surface may play an important role in the adhesion mechanisms of the Aß
peptide. Our experiments show that the neuron surfaces along with the media conditions
may be the most important causes for progressive formation of plaques. We have

viii

incubated rigid supports (mica) and soft biomimetic substrates (lipid bilayers on top of a
PEG cushion layer drafted onto a silica surface) with the three different conformations of
the Aß peptide (monomeric, oligomeric and fibrils structures) to determine the adhesion
mechanisms associated with in situ plaque formation. The soft biomimetic substrates
have been assembled first by depositing and activating a thin film of silica (i.e., to create
surface silanol groups). This film is then reacted with polyethylene glycol (PEG), which
is a biocompatible polymer, to create a cushion-like layer that supports and allows the
lipid bilayer to have high mobility. A lipid bilayer is then deposited on this soft support to
reproduce a cell membrane using the Langmuir Blodgett deposition technique. The
characterization of such biomimetic membranes has been studied by using Atomic Force
Microscopy (AFM) in liquid environments. Our results show that these lipid bilayers are
highly mobile. Additionally the structure and topography characteristics of the Aß
conformations have been followed with atomic force microscopy (AFM). The kinetics
and rates of adhesion have been measured with attenuated total reflection Fourier
transform infrared (ATR-FTIR) spectroscopy. Our results show the progress of the
plaques' formation with time where simple monomers deposit on the substrates and allow
the development of oligomeric species. The oligomers then grow into fibril-like
structures leading finally to the plaques that eventually are seen to insulate real neurons
and stop them from the synapse process. The ultimate outcome of this investigation will
contribute to understand, prevent and determine possible mechanisms for removing AD
plaques.
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Chapter One
Introduction
1.1.

Alzheimer’s Disease
Worldwide the most common cause of senile dementia is Alzheimer’s disease

(AD), an age-associated neurodegenerative disease characterized by loss of memory and
language skills, damage cognitive function, and altered behavior. The first AD’s clinical
symptoms are typically seen after the age of 65 years old [1].
After the age of 85, one out of every two people is affected either by AD or by
what is called a mild cognitive impairment (MCI) condition [2]. MCI is recognized by a
significantly reduced memory with cognition being within a normal range and is
considered as a symptom indicating the onset of dementing disorders primarily
represented by AD [2]. More than 15% of the cases of MCI turn into Alzheimer’s disease
[3]. The estimated number of AD’s cases is over 20 million worldwide and is expected to
keep growing as the world population ages [2].
The pathologic mechanisms of Alzheimer’s disease are still uncertain, however
two hallmarks are recognized: intracellular neurofibrillary tangles (NFTs) and
extracellular senile plaques [4]. The NFTs are structures composed of paired helical
filaments mainly formed of abnormally hyperphosphorylated tau protein (P-TAU) [5]
which is mainly but not exclusively neuronal microtubule-associated protein (MAP) [6].
1

Some of the roles of the tau protein are: stabilization of axonal microtubules, signaling
transduction, interaction with the actin cytoskeleton, and neurite outgrowing. The
formation of this NFT is believed to be a consequence of the amyloid plaque formation
[2]. Figure 1 shows both deposit of plaques and NFT. The extracellular senile plaques are
composed by amyloid peptide deposits of mainly 40- and 42-amino acids long (Aβ1-40
and Aβ1-42) [5]. Amyloid-β peptides do not appear to play a major physiological role
indeed the based on the original amyloid cascade hypothesis amyloid plaque depositions
or partially aggregated soluble Aβ trigger a neurotoxic cascade, thereby causing
neurodegeneration and finally pathology of AD [7].

Figure 1. Two of the Alzheimer’s Disease Hallmarks: (left) A High-power
photomicrograph of an amyloid plaque; (right) A photomicrograph of silver stained
(black) neurofibrillary tangles in the cell bodies [7]
The plaques and tangles are accumulated in neurons throughout the cortical and
limbic brain regions [5] (regions shown in Figure 2). The cortical region is responsible
for the abilities and activities related to our thinking, some examples are language and
abstract thinking, it is also involved in basic aspects of perception, movement, and
adaptive response to the outside world [8]. The limbic region is primarily responsible for
our emotional life and the formation of memories [8].
2

Based on the studies over the years a hypothesis involving plaque formation has
been proposed and studied. The amyloid-β hypothesis sustains that the main cause of AD
is the presence of this protein as the main component of the plaques that block the
synapses in the neuronal cells [9]. A historical report about the discoveries that relate AD
with amyloid-β peptides is shown in Appendix A.

Figure 2. Regions in the Brain Affected by AD

The amyloid-β is a physiological peptide is secreted from the neurons under
normal conditions in addition with other soluble peptides that are cleavaged from the
transmembrane amyloid precursor protein (APP). APP consists of a large extracellular Nterminal domain and a smaller intracellular tail (Figure 3). Apparently the soluble forms
of APP have neuroprotective and neurotrophic functions. However, Aβ is considered as
an unwanted by-product of the APP processing [2].
The Aβ peptides are found as globular and non-fibrillar forms in small
concentrations of pico- to nano-molar, and are found in the extracellular and cytoplasmic
3

(inside the cell) regions in both normal as well as AD tissues. Nevertheless, significantly
small oligomeric molecules, and non-fibrillar Aβ peptides, are sufficient to cause
profound cytoskeletal degeneration and cell death through mechanisms of plaque’s
formation still not completely understood.

Figure 3. Synthesis of Aβ in the Cell. The β-amyloid domain is partly embedded in the
plasma membrane. To generate Aβ, APP is first cleaved by β-secretase, resulting in the
release of β-secretase-cleaved soluble APP (β-sAPP). In the second step, the 99 amino
acid C-terminal fragment (C99 CTF) is cleaved by the γ-secretase complex releasing free
β-amyloid[3]
The Aβ peptides are found as globular and non-fibrillar forms in small
concentrations of pico- to nano-molar, and are present in both extracellular and
cytoplasmic (inside the cell) regions in both normal as well as AD tissues. Nevertheless,
significantly small oligomeric molecules, and non-fibrillar Aβ peptides, are sufficient to
cause profound cytoskeletal degeneration and cell death through mechanisms of plaque’s
formation still not completely understood.
Under normal conditions, in the brain there is an anabolic/catabolic equilibrium of
the amyloid-β peptide; that prevents the formation of AD plaques [2]. However, once this
4

equilibrium is broken, the protein progressively aggregates causing the plaque formation
[2]. There are more than 13,000 publications [10] concerning Aβ peptide have shown
different approaches to treat and prevent AD. These studies involve genetics and
molecular biology, among other approaches. However, among all these publications little
has been done about the interacting mechanisms of the proteins structures with the cell
membrane. In this thesis, we conduct systematic investigations to elucidate the
mechanisms between protein and membrane structures under different physiological
conditions (i.e., varying the pH, temperature of the media, and the composition of the
membrane). The surface of the neurons plays an important role in the adhesion
mechanisms of Aβ; mechanisms associated with a cascade of events that may begin with
the aggregation of monomer (seed) as bigger molecules (oligomers) that eventually result
in larger structures (fibril) that accumulates on the cell membrane forming plaques
blocking synaptic processes. It is believed that this surface coating leads to intracellular
tangles formation and finally to neuron death. Our approach is to mimic cell conditions
changing the media and characterizing the structure formation and the interaction
mechanisms of these forms using a biomimetic cell membrane.
1.2. Significance of this Work
This work represents a contribution to the “amyloid hypothesis” investigation,
that not only states that AD is characterized by the reduction and increase levels of
sAPPα and Aβ respectively when the APP metabolism is altered, but also views other
abnormalities in AD as either leading to Aβ plaque formation/deposition [11]. We are
mainly focused in answering two questions:
5

a. What are the intermolecular forces and kinetic mechanisms involved in the
formation of the different amyloid-β (Aβ40 and Aβ42) peptide
conformations (i.e., monomeric, oligomeric and fibril)?
b. What

are

the

surface

interactions

between

amyloid-β

peptide

conformations and cell membranes, and their role in plaque formation?
Therefore, this work will elucidate ways that may lead to plaque prevention
and/or removal, based on the understanding of neurotoxic structures assemble, and
surface energy features, in connection with the medium and the interacting substrate
conditions.
1.3. Research Aims
This work has been divided in three main aims:
1.3.1. First Aim
To study and compare conformation assembly for Aβ (1-40) and Aβ (1-42): This
will be done by looking at the stability of the monomeric state and the formation and
stability of oligomers and fibrils. Many studies have proven the medium influence on the
amyloid peptide conformations [12-16]. Therefore, we need to find a reproducible
conformational assembly scheme based on the medium conditions employed, these are
controlling pH, temperature, and incubation time. This study is done for the two
characteristic peptides found in the Alzheimer’s disease patients, Aβ (1-40) and Aβ (142). We are using the Atomic Force Microscopy (AFM), which allows one to visualize
the structures with a resolution within nanometers, giving topological details of the
structures.
6

1.3.2. Second Aim
To study and understanding of oligomeric and fibrillar kinetics: In order to
properly understand the adhesion mechanisms of Aβ conformations to the cell membrane
that drive to plaque formation, it is needed to understand first their kinetics of its
formation. This study is conducted using the Attenuated Total Reflection Fourier
Transform Infrared (ATR-FTIR) spectroscopy. This technique allows one to recognize
the structural chemistry of the molecules under study in real time.
1.3.3. Third Aim
To study the adhesion mechanisms: This aim is subdivided in two stages:
a. The study of adhesion behavior of monomeric, oligomeric and
fibrillar forms with variable substrates looking at the substrate
rigidity or softness dependency. This study is done by coupling
AFM and ATR-FTIR analysis.
b. To analyze the dominant processes during the aggregation of the
three Aβ conformations by deconvolution of the ATR-FTIR
spectra and the relationship of the topography ratios of the AFM
scans. For this specific aim different substrates have been used
such as mica, and biomimetic cell membranes constructed by
assembling lipid bilayers.
1.3. Structure of this Thesis
For a systematic study of the interactions between Aβ and membrane surfaces it is
needed to know some basic concepts concerning molecular biology, biological
7

interaction forces, and cell membrane (interface properties), which will be described in
Chapter two among other basic concepts.
A brief description of the systems that have been studied are presented in Chapter
three. The interest on looking at the monomeric, oligomeric and fribrillar conformations
and their relationship to AD are also explained. Additionally, a concise explanation
involving biomimetic cell membrane structural design is described.
Chapter five illustrates the technical details of this investigation and all the
protocols followed in the preparation and characterization of the systems.
The results and discussion of this work are presented in chapter six, as well as a
comprehensive analysis of the data.
The conclusions for this work along with the final suggestion and future work are
presented in Chapter seven.
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Chapter Two
Fundamentals in Biochemistry and Cell Biology
2.1. Amino Acids
Amino acids are the building blocks of proteins. A so-called α-amino acid
consists of a central carbon atom, called the α carbon, linked to an amino group, a
carboxylic acid group, a hydrogen atom, and a distinctive R group. The R group is often
referred to as the side chain. Because of the four different groups connected to the
tetrahedral α-carbon atom, α-amino acids are chiral; the two isomers are called the L
isomer and the D isomer (Figure 4). Only L amino acids are constituents of proteins [17].
Essentially, 20 amino acids are components of protein in living organisms. The properties
displayed by proteins, which in one way or another mark the path of protein aggregation,
come from amino acid features such as the capacity to polymerize, novel acid-based
properties, varied structure and chemical functionality in the amino acid side chains, and
chirality [18].

Figure 4. L and D Isomers of Amino Acids (R refers to the side chain). The L and
D isomers are mirror images of each other
9

2.2. Peptide
Peptide is the name assigned to short chains of amino acids with less than fifty
amino acid residues [17]. A common classification for peptides uses the number of amino
acid units in the chain. That is, each unit in the protein chain is called an amino acid
residue, whereas a chain of amino acids is called a sequence. The word residue comes
from the act of residing, after an amino acid forms a peptide linkage upon joining a
peptide chain. For instance, a peptide is a short chain with two amino acid residues,
tripeptides are formed by three residues and so forth. Since the terminology becomes
burdensome after 12 residues, the peptide chains with more than 12 and less than about
20 amino acid sequences are referred to as oligopeptides. According to this terminology,
only when the chain exceeds 20 amino acids in length, the term polypeptide is then used
[18].
2. 3. The Peptide Bond
Peptides and proteins are sequential and unbranched polymers of amino acids
linked head to tail. In every instance, a carboxyl group is linked to an amino group
through a type of covalent amide linkage referred to as peptide bonds [18]. When a
peptide bond is formed, the reaction releases water molecules.
The peptide “backbone” of a protein follows a repeated sequence –N-Cα-C-,
where the N represents the amide nitrogen, and the Cα is the α-carbon atom of an amino
acid in the polymer chain. A schematic of the peptide backbone is shown in Figure 5
[18].
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Figure 5. The Peptide Bond Shown in its Usual Trans-Formation of Carbonyl O and Amide
H. The Cα atoms are the α-carbon of two adjacent amino acids joined in a peptide linkage.
The dimensions and angles are average values observed by crystallography analysis of
amino acids and small peptides. The peptide bond is stippled
The geometry of the protein backbone is somewhat responsible for the unique
qualities that proteins attain. For instance, the peptide bond is essentially planar, and has
what it is considered a double-bond strength (although it is not a double-bond in essence)
that prevents free rotation around it. Also, the peptide bond is uncharged, the absence of
charge allows tightly packing of amino acid chains, linked by peptide bonds, into
globular structures [17]. Even though peptide bonds only lost or gain protons at extreme
pH conditions, the overall charge of a protein can be induced by changing the pH of the
media [18].
In contrast with the peptide bond, the bonds between the amino group and the αcarbon atom, and between the α-carbon atom and the carbonyl group are mainly single.
This causes two adjacent rigid peptide units to rotate about these bonds only and allows
the residues to take various orientations with respect to each other in the chain.
Consequently, the proteins can fold in scores of different ways owing to the free rotation
between two each amino acid groups in the chain [17].
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2.4. Proteins
In brief, the term protein defines molecules composed of one or more polypeptide
chains. Proteins having only one polypeptide chain are monomeric proteins. Proteins
composed of more than one polypeptide chain are multimeric proteins or oligomeric.
Amyloid-β and other fibril-like proteins are called homomultimeric proteins, since they
only contain one kind of polypeptide. Heteromultimeric proteins are composed of several
different kinds of polypeptide chains. Multimeric proteins are usually designated by
Greek letters and subscripts to denote their polypeptide composition such as in the case of
β-amyloid [18].
2.5. Architecture of Protein Molecules
The architecture of proteins is usually arranged as follows:
2.5.1. Protein Shape
Proteins can be organized according to their basic of shape. That is, they can be
fibrous or globular.

Fibrous proteins tend to have relatively simple, regular linear

structures, such as β-amyloid fibrils. These proteins often have structural roles in cells
(e.g., collagen and fibrinogen). Typically, they are insoluble in water or in dilute salt
solutions. In contrast, globular proteins are roughly spherical. The polypeptide chain is
compactly folded in globular proteins, so that hydrophobic amino acid side chains are in
the interior of the molecule and the hydrophilic side chains are at the outside of the
molecule. Hence, globular proteins are very soluble in aqueous solutions.[18]
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2.5.2. Levels of Protein Structure
To cope with the complex architecture of protein molecules, they have been
classified in several levels depending on their structural conformation.
a. Primary Structure
The amino acid sequence is the primary structure of a protein. A schematic
representation of this conformation is shown in Figure 6 [18].
Ala

Glu

Phe

Arg
His

Asp

Asp

Ser

Gly

Tyr

Glu

Val

His
His
Gln

Gly

Lys

Lys
Asn

Ala

Ser

Gly
Val

Asp

Glu

Ala

Phe

Phe

Val

Ile

Leu
Val

Ile
Ile

Gly

Leu

Met

Val

Gly

Gly

Val

Ala

Figure 6. Amyloid β (1-42) Peptide Visualized as a Simple Amino Acid Sequence
of 42 Residues
b. Secondary Structure
Secondary structures are one level higher than primary structures and represent a
three-dimensional arrangement of the polypeptide in space [18]. Polypeptide chains can
arrange themselves into characteristic patterns by means of hydrogen bonding
interactions between adjacent amino acid residues. These patterns can appear as helical or
pleated segments as shown in Figure 7. These segments constitute regular structures that
extend along one dimension, like the coils of a spring. Most proteins exhibit this type of
structures, and depending on the medium conditions they arranged themselves as α-helix
or β-sheet structures. Amyloid peptide structures are usually described in this
classification.
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Figure 7. Two Structural Motifs Arrange the Amino Acid Sequence into a Higher
Level of Organization Predominantly: The α-helix and the β-pleated strand. Atomic
representations of these secondary structures are seeing. The flat, helical ribbon is used
for the α-helix and the flat, wide arrow is used for β-structures. Both of these structures
own their stability to the formation of hydrogen bonds between the N-H groups and the
O=C functions within the polypeptide backbone
c. Tertiary Structure
A higher level of structure is generated when polypeptide chains assume a more
compact three-dimensional shape by bending and folding. For instance, ternary structure
allows proteins to adopt a globular. Ternary structures are usually seen in those proteins
commonly existing in cells. The globular conformation promotes a lower surface-tovolume ratio and shields the protein from interacting with the solvent [18].
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d. Quaternary Structure
Many proteins consist of two or more tertiary structures. Each of these tertiary
structures is commonly referred to as a subunit of a protein. This subunit organization in
proteins constitutes yet another level in the hierarchy of protein structure [18].
2.6. Amyloid-β Peptide and Protein Denature Process
The term amyloid was introduced in 1854 by the German physician scientist
Rudolph Virchow. In his studies, he analyzed cerebral corpora amylocea that had an
unusual and abnormal appearance when seen under the microscope. Virchow concluded
that the substance responsible for such macroscopic abnormality was cellulose and
named it “amyloid”, derived from the Latin amylum and the Greek amylon that means
“starch”. Later on, Friedreich and Kekule demonstrated the presence of protein in a
“mass” of amyloid and pointed the high nitrogen content and absence of carbohydrates.
Several events have led to the study of amyloid from a single type of protein to a class of
proteins with propensity to undergo distinct changes in conformation (denature), hence
resulting in fibril formation .[19]
For instance amyloidoses are fundamentally diseases related to denatured
proteins. The propensity to denature of such proteins may be enhanced by mutation,
environmental factors or posttranslational modifications. Additionally, some proteins are
“natively denatured” or conformationally mutable. Cells contain elaborate machinery to
ensure that proteins fold properly, such machinery includes proteins such as chaperones
and processes such as selective degradation systems. The proteasome is a degradation
system that disposes of misfolded proteins. A characteristic that distinguishes amyloids
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from other misfolded or denatured proteins is their ability to aggregate into higher order
oligomeric and fibrillar structures that allows them to evade quality control systems such
as the proteasome. Inhibition of the proteasome or lysosomal1 degradation systems can
lead to the accumulation of misfolded amyloidogenic proteins and peptides. Amyloid
aggregates also inhibit the proteasome2, most likely by adopting stably folded structures
that cannot be unfolded and therefore cannot be transported into the central catalytic pore
of the proteasome enzyme complex. It is thought that the critical initiation or nucleating
event in the formation of amyloid is the aggregation of stable β-sheet structures that may
form a seed. This system grows and propagates owing to the amyloid structure’s
relatively resistance to degradation in vivo and the
concentration
proteins.

of

aggregation

of

misfolded

Thus, a small increase in the
Nonpolar tail

concentration

of

misfolded

proteins

dramatically accelerate the onset of AD. [20]
2.7. Amphiphilic Molecules

Polar head

can
Figure 8. Representation of an
Amphiphilic Molecule: Sodium
Palmitate

The concept of amphiphilic character is very important because the amyloid-β
peptide and the lipids forming the cell membrane show this behavior. Amphiphilic
molecules are compounds that consist of both strongly polar and strongly nonpolar
groups. The name amphiphilic comes from the Greek amphi meaning “both”, and philos
meaning “loving. They are also referred to as amphipathic molecules from the Greek

1
2

Lysosomal: a membrane-bound cavity in living cells that contains enzymes that are responsible for
degrading and recycling molecules.
Proteasome: a cluster of proteins found in the cytoplasm of living cells that degrades damaged or
redundant proteins.

16

pathos meaning “passion, suffering”. Salts of fatty acids are typical examples of
amphiphilic molecules that have special biological relevance. They have a nonpolar
hydrocarbon tail and a strongly polar carboxyl head group, such as sodium salt palmitic
acid (Figure 8). Their behavior in aqueous solution reflects the combination of the polar
and nonpolar nature of these substances. The ionic carboxylate component hydrates
readily, whereas the long hydrophobic tail is intrinsically insoluble. Because of this,
sodium palmitate, a soap, shows little tendency to form a true ionic solution in water.
Nevertheless, sodium palmitate and other amphiphilic molecules readily disperse
in water because the hydrocarbon tails of these substances are joined together in
hydrophobic interactions as their polar carboxylate functions are hydrated in typical
hydrophilic fashion.
The term micelle refers to a cluster of amphiphatic molecules (Figure 9). The
amphipathic behavior of biomolecules has an enormous biological significance. The
polar ends express their hydrophilicity by means of ionic interactions with the solvent,
whereas the nonpolar ends are excluded from water and clustered into a hydrophobic
domain constituted by the hydrocarbon tails of many of these molecules. Membranes are
structures that define the limits and comportments of cells. [18]

-

-

-

- - -

- - -

-

-

-

Figure 9. Micelle Formation by Amphiphilic Molecules in Aqueous Solution
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2.8. Biomolecular Interactions
Molecules are formed by covalent bonds that allow atoms to hold together and thus
to form molecules. Weak chemical forces work mainly in intramolecular or
intermolecular attractions between atoms, such as hydrogen bonds, Van der Waals forces,
ionic bonds, and hydrophobic interactions [18]. Each force is described below.
2.8.1. Van der Waals Attractive Forces are the result of induced electrical
interactions between closely approaching atoms or molecules as their
negatively charged electron clouds fluctuate instantaneously in time. These
fluctuations allow attractions to occur between positively charged nuclei and
the electron density of the incoming atom [18].
2.8.2. Hydrogen Bonds are formed between a hydrogen atom covalently bonded
to an electronegative atom (such as oxygen or nitrogen) and a second
electronegative atom that serves as the hydrogen bond acceptor. Hydrogen
bonds are stronger than Van der Waals forces (as Table 1 shows) and have
an additional property. That is, H bonds tend to be highly directional,
forming straight bonds between donor, hydrogen, and acceptor atoms[18].
Hydrogen bonds are also more specific than van der Waals interactions
because they require the presence of complementary hydrogen donor and
acceptor groups. This type of bond has a remarkable influence in the
possible structures that a molecule can adopt.
2.8.3. Ionic Bonds are the result of attractive forces between oppositely charged
polar molecules, such as negative carboxyl groups and positive amino
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groups.

Since the opposite charges are restricted to sterically defined

positions, ionic bonds can impart a high degree of structural specificity.[18]
2.8.4. Hydrophobic Interactions are due to the strong tendency of water to
exclude nonpolar groups or molecules. Hydrophobic interactions arise from
water molecules which prefer and share stronger interactions with one
another. Since the strongest chemical interaction that is possible between
two molecules actually determines its properties, the preferential hydrogen
bonding interactions between polar water molecules excludes nonpolar
groups. It is this exclusion of nonpolar groups that drives their tendency to
cluster in aqueous solution. Thus, nonpolar regions of biological
macromolecules are often in the molecule’s interior of the system, so that
they are excluded from the aqueous environment. [18]
One of the reasons why living systems are restricted to a narrow range of
environmental conditions is due to the fact that weak forces are present in biomolecular
interactions. Biomacromolecules are functionally active only within a narrow range of
media conditions, such as temperature, ionic strength, and alkalinity. Extremes situations
of these conditions disrupt these weak forces, which are essential to maintaining the
intricate structure of macromolecules. The loss of structural order in these complex
macromolecules is called denaturation, and it is inevitably accompanied by loss of
functionality. [18]
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Table 1. Comparison of Biomolecular Interactions
Force

Strength

Distance

(kJ/mol)

(nm)

0.4 - 4.0

0.2

12 – 30

0.3

Ionic bonds

20

0.25

Hydrophobic

< 40

-

Van der Waals
interactions

Hydrogen
bonds

interactions

Description

Strength depends on the relative size of the
atoms or molecules and the distance between
them. The size factor determines the area of
contact between two molecules. That is, the
greater the area, the stronger the interaction.
Attractive VDW forces are inversely
proportional to the sixth power of the
distance, r, separating two atoms or
molecules: F ≈ 1/r6.
Relative strength is proportional to the
polarity of the H bond donor and H bond
acceptor. More polar atoms form stronger H
bonds.
Strength also depends on the relative polarity
of the interacting charged species. Some
ionic bonds are also H bonds:
− NH 3+ ... − OOC −
Force is a complex phenomenon determined
by the degree to which the structure of water
is disordered as discrete hydrophobic
molecules or molecular regions coalesce.

2.9. The Neuron Cell Membrane
As it has been explained so far, the Aβ plaques are found on the surface of the
neurons, hence it is important to identify what else is present on their surface. Therefore,
the neuron cell membrane is the outer most surface facing the plaques and defines the
boundaries that separates the inside and outside of the neuron cell. A lipid bilayer makes
the backbone of cell membranes.
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To next
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Figure 10. Schematic Representation of a Neuron Picturing the Cell Membrane
Membranes resemble supramolecular complexes in their construction since they
are complexes of proteins and lipids maintained by covalent forces (Figure 8).
Some proteins traverse the lipid layer and influence the cell membrane structure.
Some are for structural support, whereas others are receptors, channels or tunnels that
allow passage of certain molecules into and out of the cell. Thousands of these channels
populate the cell membrane and allow passage of the ions. For instance, sodium is a
major player to the neuron cell because of its positive charge. This ion flows across the
membrane in different ways depending on the exact status of excitation of the neuron.
Additionally, in the case of cell membranes, the hydrophobic interactions are particularly
important in maintaining the membrane structure. These interactions reflect the tendency
of nonpolar molecules to come together as they are excluded by a polar solvent. [18]
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Chapter Three
Chemistry and Conformations: Amyloid Peptide and Cell Membrane
3.1. Amyloid-β Peptide Conformations
3.1.1. Monomers
Monomers are about 1.0 ± 0.3 nm in size [16], with a molecular weight of: 4329.9
Da for Aβ (1-40) and 4514.1 Da for Aβ (1-42) (Appendix E). Monomers present mostly
random coils and α-helix secondary structures (Figure 7).
The conformation of Aβ (1-40) and Aβ (1-42) single monomers can be visualized
in Figure 11. These models have been generated using a comparative modeling online
resource called 3D-JIGSAW (version 2.0). For this program, the source protein sequence
is entered and then a mathematical model is developed based upon the potentials data that
its bank holds assuming that there are not internal or solvent interactions whatsoever. The
complete sequences for the Aβ (1-40) and Aβ (1-42) are provided in appendix E.

Aβ(1-40)

Aβ(1-42)

Figure 11. Alzheimer’s Disease Amyloid-β Peptide Monomer Theoretical
Configuration
22

Monomers

are

highly

stable

in

fluorinated

alcohols

including

hexafluoroisopropanol (HFIP) and trifluoroethanol (TFE). These alcohols disrupt
hydrophobic forces in aggregated amyloid preparations, and promote α-helical secondary
structures [16]. By dissolving Aβ peptides in 100% HFIP, the resulting structures for Aβ
(1-40) and Aβ (1-42) solutions are mostly α-helical (~50-70%) and random coil (~3050%), with a little β-sheet secondary structures (<1%) [16].
3.1.2. Oligomers
The oligomers also known as protofibrils are considered by several authors [2123] as intermediate configurations in the fibrillogenic process. Oligomers are soluble
spherical aggregates of 2-20 nm and have been study for many different types of
amyloids with electron and atomic force microscopy [16, 20]. These spherical
conformations appear at intermediate times of monomeric incubation and disappear as
fibrils appear, suggesting that they are an intermediate step in the pathway of fibril
formation. Their sizes vary depending on the number of monomer aggregates. The size of
this quasi-stable intermediate aggregate ranges from dimmers up to particles of a million
Da or greater and have been observed by a several techniques including SDS gel
electrophoresis, fluorescence resonance

energy transfer, light scattering, and atomic

force microscopy [16, 20].
3.1.2. Fibrils
Many proteins assemble into amyloid fibrils, even those that are not disease
related. Amyloid fibrils are approximately 6-10nm in diameter. The unbranched fibrils
are characterized by a “crossed β-sheet” structure (Figure 7) in which the polypeptide
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chain is oriented perpendicularly to the fiber axis with the hydrogen bond parallel to the
axis. The ability to form amyloids is not limited to disease related proteins. Rather, it
appears to be a fundamental polymer motif of the polypeptide backbone, although it is
not commonly observed in native proteins. Specific sequences or side chain interactions
are not required for amyloid formation, since many different polyamino acids form
crossed β-sheet amyloid fibers. This also suggests that the fundamental tendency to form
amyloids is overcome by the fact that specific sequences tend to adopt stable structures
with time.
3.2. Common Pathways of Aggregation amyloid-β peptide
One particular hypothetical pathway for Aβ fibril assembly is depicted in Figure
12. The earliest event in the process of aggregation is the formation of dimmers. Aβ
derived from a segment of APP is believed to be predominantly α-helical in its native
state. On the other hand, monomeric Aβ is largely conformed as random coil in solution.

Figure 12. Pathway of Aβ Aggregation and Fibril Formation.
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The formation of Aβ dimmers coincides with the adoption of partial β structure. The Aβ
dimmers assemble into higher order aggregates or oligomers, since there is a remarkable
increase in the amounts of higher order aggregates and a decrease in the amount of
dimmers.
These higher order Aβ aggregates are protein micelles with a hydrophobic core
and a polar exterior that appear as 3 nm spherical particles determined by atomic force or
electron microscopy [20].
At later times, these spherical shape particles appear to form curvilinear strings or
“protofibrils”. The protofibrils undergo a conformation change to form the straight,
unbranched mature fibrils. Once the amyloid fibril lattice has been established, the fibril
can grow by the addition of Aβ monomer or dimmer at the ends of the fibril. The higher
order aggregates have molecular weights ranging from approximately 105 to 106 Da and
with an average size corresponding to approximately 24 monomers. Aβ oligomers that
appear as spherical particles are approximately 3 nm in diameter and have the
characteristics of a protein amphipathic, since it lowers the surface tension of water.
Formation of high molecular weight aggregates displays a critical concentration of
approximately 25µM [20] and it is correlated with the formation of a new hydrophobic
environment. At longer incubation times, the oligomers also appear to co-aggregate to
form curvilinear fibrils with a characteristic beaded appearance. The spherical oligomers
and protofibrils appear to be intermediates in the pathway of fiber formation because they
disappear as mature fibrils accumulate and the rate of monomer dissociation from them is
too slow to account for fibril growth. The transition appears to involve a major
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conformational change, because fluorescence quenching analysis indicates that the
carboxyl terminus is highly shielded from the aqueous solvent in the soluble oligomeric
state, whereas it is exposed to the solvent in the fibrillar state. Once the amyloid fibril
lattice has been established, it can grow by the addition of monomers onto the ends of the
fibrils. [20]
Additionally, numerous in vitro studies have indicated that Aβ oligomers are toxic
to cells or interfere with the normal function of neurons [21-23]. Mounting evidence
indicates that soluble amyloid oligomers are generally toxic for a wide variety of disease
related amyloids. Moreover, soluble oligomers are intrinsically toxic even though they
are formed by proteins that are not disease related. The idea that soluble Aβ oligomers
may play a primary role in AD pathogens is attractive, however, the evidence to support
it is largely correlative and derived from in vitro toxicity studies. In order to evaluate the
role of soluble Aβ oligomers in diseased human brain, there needs to be a way to
distinguish them from soluble Aβ monomer, APP and Aβ fibrils. All of these species
contain the same amino acid sequence, but differ in conformation [20]. These
conformations are analyzed separately in this work.
3.3. Biomimetic Cell Membrane
Biomimetic cell membranes are used to represent the neuronal surface. This cell
membrane model interacts in vitro with the three conformations of the amyloid-β
explained above and is built with features of real cell membranes.
A double layer of lipids molecules makes up the main substance of the cell
membrane. Lipids containing phosphorus in their head group are called phospholipids. In
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the cell membrane, some molecules such as cholesterol (there are mainly three types of
cholesterol lipids: phosphoglycerides, sphingolipids, and sterols), and proteins are located
between the phospholipids. Cholesterol is known to strengthen the membrane and
promotes rigidity. A variety of different proteins float within the phospholipids. Some
proteins act as receptors in the cell, that is, as points of attachment for materials coming
to the cell in the blood or tissue fluid. Additionally, enzymes are also participating in
reactions occurring at the plasma membrane. Some are transporters, shuttling materials
into or out of the cell, and some form channels through which only selected substances
can pass. Carbohydrates are present in small amounts, combined either with proteins or
with lipids. These carbohydrates cells help to recognize each other and to adhere to one-

Figure 13. Model of a Prototypical Cell Membrane.
another. A representation of a model cell membrane is shown in Figure 13 [24]. Lipid
bilayers are represented by outer, hydrophilic (exposed to an aqueous environment) and
inner, hydrophobic (maintains a barrier to solute movement) domains. Inserted through
the membrane or in either inner or outer planes are various proteins that permit transport,
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cell-to-cell and signal molecule interactions, and linkage of the membrane to the
intracellular cytoskeleton along with cholesterol and carbohydrate molecules.
Additionally, most biological membrane lipids are composed by double-chained
phospholipids or glycolipids with 16 to 18 carbons per chain, one of which is unsaturated
or branched. These properties are not accidentally but carefully design by nature to
ensure:
a. Biological lipids will self-assemble into thin bilayer membranes that can
compartmentalize different regions within a cell, as well as protect the
inside of the cell from the outside.
b. Because of their extremely low critical micelle concentration (CMC) the
membranes remain intact even when the bathing medium is grossly
depleted of lipids.
c. Due to unsaturation or branching, the membranes are in the fluid state at
physiological temperatures which let them deliver various molecules
through them.
The construction of the membrane for this work will be done on a substrate such
that it allows the lipid bilayer to be in a mobile state, supported by a soft cushion. Such
conditions simulate the real conditions of cell membranes. Preliminary studies involving
just a simple lipid bilayer were performed. However, future work involves the addition of
a new component to the bilayer to tune its mobility and surface conformation. We will
also study the response of these model membranes the three different conformation of the
amyloid β peptide (i.e., monomers, oligomers and fibrils).
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Chapter Four
4. Experimental Methodology and Characterization Techniques
4.1. Surface Deposition Techniques
Two deposition techniques are mainly used in this work, one is a chemical vapor
deposition based on oxidation reaction and the other is a physical deposition based on
interacting forces. Both deposition techniques are described below.
4.1.1. Plasma Enhanced Chemical Vapor Deposition
Plasma enhanced chemical vapor deposition (PECVD) is a thin film deposition
method that is used to deposit thin film on metals and other materials that cannot sustain
high temperature. It takes place at relatively low temperatures (< 300 ºC) due to the use
of a radio frequencies (RF) source that induces a plasma discharge to transfer energy into
the reactant gases. The ionized gas (plasma) breaks down the gases and the activation
energy barrier is lowered forming radicals (decomposition). These radicals produce many
instable and stable species in the vapor phase, which then react with each other to form
heavy stable molecules and deposit into a film.
In this work, PECVD is utilized to deposit a thin layer of silica (i.e., silicon
dioxide (SiO2)) that is later use as the substrate for a reaction with polyethylene glycol
(PEG) that ultimately serves as the cushion support for the biomimetic model
membranes.
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The silica films are produced by reacting SiH4 and O2 gases in this reactor (Figure
14). The plasma is produced by a helical resonator discharge source using RF powered
copper coil at 13.56 MHz [25].

Figure 14. General Schematic Diagram of a Plasma Enhanced Chemical Vapor
Deposition Reactor
PECVD is also used to produce water
plasma

(see

Figure

15).

Water

plasma

treatments are used to increase the hydroxyl
group concentration on the silica surface
controllably and reproducibly. The conditions
for this process were established previously, so
that the silica surface is completely saturated
Figure 15. Water Plasma is Induced
the surface with hydroxyl groups, without over the Silica Surface to Create Active
SiOH Species that React with PEG to
roughening the surface [25].
Produce a Soft Polymeric Support for
the Model Membranes
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4.1.2. Langmuir-Blodgett Deposition
The Langmuir Blodgett deposition technique is used to deposit compact and fine
organized monolayers. The molecules that are deposited can be organic or inorganic, but
with amphiphilic nature. The monolayer is formed on the surface of the subphase (water)
by dissolving the amphiphilic substance in a suitable solvent. In this investigation
chloroform is used to dissolve the lipids that form the monolayer on the water surface.
Once the monolayer is formed the deposition takes place upward or downward
depending on the nature of the substrate and on the type of deposition that is been
pursued (See Figure 16). The deposition is explained in more detail in the next Chapter.
Bilayers or multilayer can be deposited with this sophisticated technique but

X-type

Y-type

Z- type

Figure 16. Types of Deposition Using LB Based on the Order of Layers.
simple. The deposition of the biomimetic cell membrane is constructed as the type Y
(Figure 16). However, we have a PEG monolayer instead of an initial monolayer of
lipids.
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4.2. Physical and Chemical Characterization techniques
4.2.1. Atomic Force Microscopy (AFM)
The Atomic Force Microscope

Z Piezo

(AFM) also known as Scanning Force
Microscope (SFM) or Scanning Probe
Microscope

(SPM).

This

technique

allows one to visualize topographies of

Segmented
Photodiode
Detector

samples in very small ranges with
resolution of about 10 pm [26].

Cantiliver
Sample

X-Y Piezo
Stage

The

AFM technique operates by measuring
Figure 17. Atomic Force Microscope

attractive or repulsive forces between a

tip and the sample. As the tip is drag through the sample surface a profile of heights is
constructed as function of the cantilever deflection lectures that are translate into a real
image of the surface under study [26]. There are two types of operational modes: contact
and non contact. In its repulsive "contact" mode, the instrument lightly touches a tip at
the end of a leaf spring or "cantilever" to the sample, moreover in contact mode the AFM
measures hard-sphere repulsion forces between the tip and sample; this mode is mostly
use when working in solid-liquid interfaces. In non contact mode, the AFM derives
topographic images from measurements of attractive forces; but the tip does not touch the
sample. This is also referred as tapping mode and it is mostly used for solid-gas
interfaces. In this investigation where used both modes, due to the characteristic of the
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medium as will be explained in the following chapter. Figure 17 shows a schematic
representation of a common AFM. [26]
4.2.2. Attenuated Total Reflectance Fourier Transform Infrared
(ATR-FTIR) Spectroscopy
Infrared spectroscopy is being widely use for the analysis of peptides and proteins
due to its reliability of probing the universally available amide (peptide) bonds, which
show a distinct IR signals for differently folded peptides and proteins [27].
Fourier transform infrared (FTIR) spectroscopy has being predominantly utilized
to study the secondary structure (α-helix and β-sheets) of proteins in recent years.
Proteins or polypeptides have a continuous chain of amino acids connected via amide
bonds also known as the “peptide bond”. The frequency at which amide bond vibrations
occur can be attributed to different secondary structures in which the amide bonds are
present. The differences in vibration of the amide bonds are due to different hydrogen
bonding among amino acid residues (see Appendix D.2). For instance, α-helix and βsheet folding have ordered hydrogen bonding, although differing in their patterns. The
differential pattern in H-bonding, along with geometric orientations of amide bonds in αhelix, β-sheet, and random coil structures allows the different vibration frequencies
associated with individual secondary structural folding. Amide vibrations (see Appendix
D.1) in-plane mode involve C=O stretching, C-N stretching, N-H stretching and O-C-N
bending, while an out-of-plane mode is due to C-N torsion [28]. These vibrations result in
characteristic spectral features of proteins. Three major spectral regions (amide I, amide
II, and amide III) have been identified based on theoretical and experimental studies [27].
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The amide I vibration region, (1700-1600 cm-1), has been widely used due to its
strong signal exhibited by proteins in this region. However, there are several difficulties
encountered in this region when analyzing protein spectra. The first difficulty
encountered in this region is the OH vibrations caused by liquid water and water vapor
that need to be subtracted out of the protein solution spectrum. Another problem is the
difficulty of peak assignments. Since there is a greater deal of overlapping of peaks
representative of the different secondary structures, it is difficult to assign bands to their
correct structure. For example, bands at 1650-1655 cm-1 could be assigned either to αhelix or random coil. Using the amide III region (1220-1320 cm-1), many of these
problems are resolved. In the amide III region, OH vibrations due to water do not
interfere with spectrum in the amide III region as much as in the amide I region. The
overlapping of bands arising from different secondary structure of a protein is not
significantly encountered in this region. In the amide I region, the frequencies at which
the different amide bond vibrations occur are not as localized as they are in amide III. In
the amide III region, various spectral bands are more resolved in the original protein
spectrum than they are in the amide I spectra. This fact allows a greater ease in peak
refinement, as well as in peak assignment. The only drawback in using amide III is that
the protein signal is significantly weaker than the signal obtained in the amide I region
[27] as is shown in Figure 18, where two proteins has been superimposed: αchymotrypsin, and fibrils of Aβ1-42 (this was a sample taking after 10 hours of
preparation).
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Because IR spectroscopy does not affect protein and peptide samples either in
solid or liquid form, it can be used for data collection. Two types of sample accessories
are typically used: Windows such as calcium fluoride, and attenuated total reflectance
(ATR) accessory, generally made of zinc selenide or germanium. For protein absorption
studies, or for studies with solid powder and thin films, ATR accessory is most
commonly used for sampling. One of the advantages of ATR technique in recording
protein spectrum is the avoidance of solvent interference in IR spectra, because it limits
the effective sample thickness to a thin layer near the surface of an internal reflection
crystal (Figure 19) [27].
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Figure 18. IR Spectrum of α-Chymotrypsin (black line), and Fibrils of Aβ1-42 (in
blue). The amide I region (1600-1700cm-1) corresponds to the C=O stretch weakly
coupled with C-N stretch and N-H bending. The amide II region (1500-1600 cm-1)
represents C-N stretch strongly coupled with N-H bending. The amide III region
(1200-1350cm-1) is N-H in-plane bending coupled with C-N stretching and also
includes C-N and N-H deformation vibrations
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Once the spectra are obtained, protein band positions are identified after spectral
processing by Fourier self-deconvolution and/or second-order derivatization. A variety of
software packages are available commercially.
Sample
In

Out

Flow cell

IR
ZnSe Crystal

-OH CH2- C=O NHX C=C-

Figure 19. Schematic Diagram of Light Undergoing Multiple
Reflections in an ATR - FTIR Spectrometer
The data obtained from the deconvolved and second- derivative spectra are used
to determine the number of bands and their positions in order to resolve the protein
spectrum into their components.
This is accomplished with a curve-fitting process employing computer software
commercially available from the manufacturers of IR instruments. The software resolves
the original protein spectrum to individual bands that fit the spectrum. Two main
parameters control the fitting process: (1) the individual bands, and (2) the baseline
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position. Each individual band in turn is controlled by three parameters:
a. The height of the band.
b. The position of the band (wavenumber).
c. The bandwidth at half-height.
The program iterates the curve-fitting process, and each iteration flows (increases or
decreases) each parameter (height, bandwidth, position and baseline) to determine
individual parameters in order to achieve the best Gaussian, Lorentzian, or a mixture of
Gaussian/Lorentzian-shaped curves that fit the original protein spectrum. A best fit is
determined by the root mean square (rms) of differences between the original protein
spectrum and the strength of individual bands. In order to estimate the strength of
individual band, the band area or intensity is used to calculate the relative contribution of
each band(s) to a particular secondary structure of the protein.
Additionally the fractional areas of the fitted component bands are directly
proportional to the relative proportions of structure that they represent. The percentage of
helices, β-structures and turns may be estimated by addition of the areas of all of the
components bands assigned (after deconvolution) to each of these structure (based on the
specific wavelengths this structures are) and expressing the sum as a fraction of the total
area [28].
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Chapter Five
Experimental Design and Procedures
Regarding the reagents used in the experiments, section 5.1 describes most of
these in Table 2. Details about peptide composition can be found in Appendix E. Table 3
describes the instrumentation and related materials.
5.1. Reagents and Materials
Table 2. Primary Reagents Used
Reagents

Acquired From

Appearance

Amyloid-β peptide (1-40)

Aβ(1-40)

American Peptide INC

White powder

Amyloid-β peptide (1-42)

Aβ(1-42)

American Peptide INC

White powder

1,1,1,3,3,3-Hexafluro-2Propanol (pa: >99%)

HFIP

Fisher Sci. ACROS Org.

Viscous- Transparent
Liq.

Me2SO or
DMSO

Fisher Sci. ACROS Org.

Transparent Liq.

Dulbecco's Phosphate
Buffered Saline powder

PBS

MP.Biomedicals

White powder

Tris (Crystallized) p:>99%)

Tris

Fisher Sci. ACROS Org.

White powder

Polyethylene glycol
(400Da)

PEG

Sigma

Transparent Liq.

1,2-Dipalmitoyl-snGlycero-3-Phosphoethanolamine-N-

DSPE
(lipid)

Avanti Polar Lipids, INC.

Powder partially
dissolve in chloroform

NH3OH

Fisher Sci. ACROS Org.

Transparent Liq.

Hydrochloric acid (HPLC)

HCl

Fisher Sci. ACROS Org.

Transparent Liq.

Sodium chloride

NaCl

Fisher Sci. ACROS Org.

White fine granules

Sodium hydroxide

NaOH

Fisher Sci. ACROS Org.

White pellets

Methyl Sulfoxide
Anhydrous (p:>99%)

Ammonium hydroxide

a

purity
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The water used for all the experiments is ultra purified and obtained from a
Millipore Water (Milli-Q) station with a resistance <18MΩ, and organics content <5ppb.
Table 3. Instrument Description and Miscellaneous Materials
Material / instrument
Centrifuge
Laminar flood cabinet
Vortex
Atomic Force Microscope
(AFM) for gas/solid Int.
Cantilevers

AFM liquid/solid Int.
Cantilevers

FTIR Spectrometer

PECVD Reactor

L-B Trough

Description
Fisher Sci., model AccuSpin-400
Forma Sci., 95 fpm & 98 fpm
Fisher Sci., Volts 120 Vac, Watts 150, 50/60 Hz
DI Dimension 3000. Tapping Mode.
Silicon. Nanosensors INC. R= 0.01-0.025 Ohm/cm, L=132 µm,
diam.=15nm, fo=281-339 kHz, k=28-54 N/m.

Asylum Res. Corp. Contact mode. The cantilever used is
special for contact mode, and is made of
SiN. L=60µm, diam.=>80nm, fo=37-13 kHz, k=0.027-0.006 N/m
Nicolett, FT-IR 850 Bench
Six-way stainless steel cross vacuum chamber with a 16-in
long, 2-in-diam Pyrex cylinder connected to the feedthrough
port at the top. With a helical resonator discharge source using
a radio-frequency (rf) powered copper coil at 13.56 MHz, and
surrounded by a grounded cylindrical copper shield enclosing
the Pyrex tube. The rf power, provided by a RF Plasma
products model RF5S power supply
Nima Technology, Model 611D

Sonicator

Fisher Sci. Model FS30

pH meter

Fisher Sci., Accumet 1003

Water Bath
Miscellaneous

Precision 180 series water bath, T range: RT + 5 to 100°C
All gas tight Hamilton syringes, Pipettes, Adjustable micro
Ependorf pipetters; Autoclaved Pipette tips, Ependorf Micro
Tubes (1000µL). Dessicator. Mica. Silicon/Silica wafer.
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5.2. Experimental Procedures
5.2.1. Conditioning of Aβ Peptides and Synthesis of Structures
5.2.1.1. Aβ1-40 and Aβ1-42 Peptides
Lyophilized peptide (1mg) kept at -20°C was removed from the freezer and let
equilibrated for 30 minutes at room temperature (RT). The peptide is then dissolved in
HFIP following the procedure described by W. Blaine Stine et al. [29]. HFIP is used to
break any residual tertiary and β-sheet secondary structure of the peptide. The peptide is
composed by α-helix (~50-70%) and random coil (~30-50%) structures mainly [29]. The
HFIP is then injected into the peptide flask with a gas-tight Hamilton 0.5ml glass syringe
until a concentration of 3.33µg/µl is obtained. Peptide dissolution takes not longer than
five minutes. Such stock solution is aliquoted into 25 parts and storage in sterile micro
centrifuge tubes of 12.5µl, containing 40µg of Aβ each approximately. Thus, each micro
tube contains 9.238 nmol and 8.861 nmol for Aβ (1-40) and Aβ (1-42), respectively.
Aliquoted samples are left under the laminar-flow hood to allow the HFIP to evaporate.
The peptides are then placed for 12 hours in a desiccator at a vacuum of 27 in Hg. The
final peptide samples have an even appearance (i.e., transparent film), which is
appreciated at the bottom of the Eppendorf tubes. The tubes with the peptide are flushed
and closed with nitrogen, wrapped with aluminum foil and parafilm, and enclosed in a jar
at -20°C for later used.
5.2.1.2. Amyloid-β Conformations
a. Monomers
The following procedures are the same for both 1-40 and 1-42. 40µg of pretreated
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Aβ peptide is removed from the freezer and let to equilibrate at RT. The pretreated
peptide is dissolved in 2µL of DMSO, which is a polar, water-soluble organic solvent
commonly used to solubilize hydrophobic peptides. After a minute of sonication with
DMSO, 88µL of milli-Q water are added to the sample. Finally, it is incubated at RT
[29].
b. Oligomers
First, a tris/NaCl/HCl buffer solution is prepared. This buffer serves as incubation
media for the oligomer’s synthesis. The buffer is prepared in an Eppendorf of 50ml,
where 0.3028g of tris and 0.2922g of NaCl are dissolved in DI water until the pH is fixed
to 7.4. Sometimes a few drops of concentrated HCl need to be added. The pretreated
peptide film kept at -20°C is then dissolved in 2µL of DMSO, sonicated for 1 min, and
then incubated at 4°C in 88µL of Tris/NaCl/HCl. This procedure is described in detail by
Kayed et al. [30].
c. Fibrils
The first step to incubate Aβ fibril structures is to prepare a solution of
ammonium hydroxide at pH=8.5. The next step is to prepare a PBS buffer. Fibrils are
prepared by dissolving 40µg of the pretreated peptide (at RT) in 20µL of NH3OH and
later adding 20µL of PBS. The sample is gently vortexed and finally incubated at a
concentration of 1µg/µL at 37°C. This procedure was suggested by Dr. David Morgan
(PhD) from the Department of Pharmacology & Therapeutics in the College of Medicine
at the University of South Florida (USF), and director of the Alzheimer Research
Laboratory at USF.
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5.2.2. Surface Characterization of the Amyloid Peptides Topology
The sample deposition procedure is conducted under laminar flow cabinet to
avoid contamination by undesirable particles. The samples to be analyzed with the AFM
are deposited on mica, which is an inert, smooth, and easily to clean mineral, and widely
used for biological samples in AFM imaging. Mica sheets are freshly cleaved prior to
each deposition. A small Teflon O-rings (external Φ 4.45mm, internal Φ 1mm) is used as
an incubation chamber placed on top of the mica which ensure the maintenance of the
desired location of fibril formation. 3µL of each incubated sample are dissolved with
ultrapure water until a concentration of 20µM is reached. This concentration has been
tested as the optimum to produce fibrils in a control manner. A small drop of such
solution is then deposited on mica and incubated for 5 min, flushed with 3mL of ultrapure
water, dry with ultrapure nitrogen, and stored in a desiccator under vacuum (30 torr) for
later AFM study.
5.2.3. Chemical Characterization of Amyloid Peptides
No fibrils were observed when Aβ40 peptide was incubated. Therefore, the
chemical characterization was done only for Aβ42 peptide conformations. The chemical
analysis is done using an ATR-FTIR spectrometer, and a zinc selenide ATR crystal. The
ATR cell allows a maximum volume of 62µL solutions (Figure 19). The crystal was first
cleaned with isopropanol, and then a fresh media solution was flushed before peptide
contact. The background for the IR data was taken when the ATR crystal was in contact
with non-peptide media. Spectra were taken at about 10 min intervals for about 3 hours
for monomers, 10 hours for oligomers, and 12 hours for fibrils, which is the time that it
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took for the samples to reach saturation and steady state conditions. This part of the study
was conducted in the Materials Research Laboratory at the University of California-Santa
Barbara (UCSB).
5.2.4. Biomimetic Cell Membrane Construction and Studies of Interaction
with Amyloid-β Peptide
5.2.4.1. Soft –Support Layer
Polyethylene glycol (PEG) is used to build the soft support layer. PEG is a linear
or branched neutral polyether soluble in water and most organic solvents. Its chemical
formula is: HO-(CH2CH2O)n-CH2CHOH.

PEG is utilized in this study because its

biotechnical applications. In fact, Norma Alcantar and collaborator have studied this
polymer widely [25] , including its use as cushion substrate or coating polymer. PEG is
unusually effective at excluding other polymers from its presence in aqueous solution,
such as lipids. This property is directly related to the fact that PEG rejects proteins and
forms two-phase systems with other polymers; it is nontoxic; it has immunogenicity and
nonantigenicity; it does not harm active proteins or cells even if it interacts with cell
membranes; it attaches to other surfaces with very little effect on their chemistry; and it
increases the solubility of large molecules despite their size. In addition, PEG coated
surfaces become hydrophilic and protein rejecting. Therefore in our study we are insuring
there is no absorption of the Aβ to the silica surface, if there is any adhesion, it is due to
the interaction of the lipids themselves with this peptide. The inert character of PEG is
based on its molecular conformation in aqueous solution, where PEG exposes uncharged
hydrophilic groups and shows very high surface mobility (steric exclusion). It is worth
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mentioning that in order to maintain its biological and biocompatible properties, the PEG
has to be chemically attached to the surface. PEG is grafted to silica films deposited on
silicon wafers creating a thin hydrophilic film. The silica deposition takes place reacting
silane (SiH4) and O2 gases in a PECVD reactor (Figure 14). The samples are then
exposed to a water plasma treatment in order to increase the hydroxyl group
concentration on the surface controllably and reproducibly [25]. Finally, the surfaces are
storage on a dry and free of particles container.
Concentrated sulfuric acid is used for cleaning the surfaces by submerging them
overnight, and then are rinsed with DI water, dried with ultrapure nitrogen, and exposed
to UV-light for about 5 minutes. The reactivation is done by submerging the surfaces in a
NaOH solution at 10 %w for about 5 minutes. The surfaces are then rinsed with water
and dried very well, since any traces of water could interfere with the PEG reaction. In
the meantime, a solution of PEG (of wt ~ 400Da) is heated until it reaches 100°C
maintaining constant agitation. The cleaned and activated surfaces are placed into the
PEG for one hour. These parameters have been determined previously by Alcantar et. al.
[25]. Once the PEG grafting reaction is done, the surfaces are retrieved from the hot PEG
and gently rinsed with water (avoiding direct contact with the flux o water), and dried
with ultrapure nitrogen. Sometimes the surfaces with PEG that are not used at the
immediately after the reaction are storage in PEG media.
5.2.4.2. Lipid Deposition
The lipid bilayers are deposited onto the soft-support PEG layer using a Langmuir
Blodgett (LB) trough (Figure 20). The first step is to ensure that the LB trough is
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impeccable, since it is very important to avoid particles clinging to the surface. These
particles can contaminate and perturb the deposition quality. To clean the trough, we use
DI water and sometimes organic solvents. We look at the quality of the water by
watching for bubble formation. Bubbles are a sign of contamination. A suction tube is
used to eliminate these bubbles out of the water without touching the surface of the
trough avoiding damage to the trough surface. The water is suctioned several times until
non-bubbles are observed.

Figure 20. Langmuir-Blodgett Trough. The principal components the trough are
highlighted in this photo
The LB trough is plugged to a computer that allows one to control parameters
such as surface area, superficial tension, and substrate deepness necessary for the actual
deposition. The trough is located inside of a laminar flow cabinet, which turn on when
the trough is being cleaned. However, the air flow is off, while the lipids are being
compressed or deposited. Once the water surface is clean, the surface pressure sensor is
calibrated to 0 N/m. An isotherm is recorded using a velocity of 50 cm2/min. The trough
45

is clean and ready to used, if the isotherm is a straight line. The target surface is
submerged for the deposition in the back socket of the trough. The trough is cleaned once
more to avoid any possible particles introduced by the surface. Another isotherm is run to
ensure cleanliness. The pressure is set to zero and the surface area is set to 300cm2. The
area, deposition pressure, and lipid concentration used for the depositions were chosen
based on previous experiments. Typical lipid concentrations are 15 µg/µL. A total
volume of 100 µL is gently spread on the air/water interface using a syringe (giving it
about 5 minutes for the solvent to evaporate). During the deposition, the surface pressure
is kept constant at 30 mN/m. The deposition takes place at constant pressure and using a
barrier velocity of 50 cm2/min (Figure 21).

Figure 21. Schematic of Lipid Bilayer Construction. (upper left) PEG grafting reaction,
(upper right) bilayer deposition, and (bottom) soft supported bilayer
5.2.4.3. Surface Topography
The soft-supported membranes constructed above have also been scanned by
AFM in solution. They are kept in contact with saturated lipid solution at all times to
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avoid air exposed and consequently, damage to the sample (Figure 22). The biomimetic
cell membranes were also scanned while in contact with Aβ fibrils (0.933 µM). Scans are
shown and explained in the next chapter.

Figure 22. Picture of the Wafer Contented in the Petri Dish. This is were the biomimetic
membrane has been deposited
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Chapter Six
Results and Discussion
This work is based on the fact that real interactions of Aβ peptides, with both 40
and 42 amino acid sequences, could be controlled and studied by following a
comprehensive approach. The control on the structure of the Aβ peptides was done by
optimizing the incubation conditions previously studied by Stine et al. [29] and Kayed et
al. [30]. Depending on the conformation that is being pursued (i.e., monomeric,
oligomeric and fibrillar), the peptide molecules will adopt diverse structures that defined
their physical and chemical pathways of aggregation, which evolve with time. By tuning
and promoting specific conformations, we were able to explicitly distinguish the response
of the peptide in terms of their assembly, surface adhesion, chemical composition and
kinetics. Explicitly, our results are three-fold:
a.

We resolved the differences of behavior depending on the number of amino acid
residues contained in each peptide molecule (i.e., Aβ-40 and Aβ-42)

b.

We promoted structural rearrangement depending on the incubation media and
substrate character

c.

We were able to correlate peptide structures (i.e., α-helix, β-sheet, β-turns, or
random) with the adhesion dynamics and ultimately, to determine the role of
molecular stability of the peptide that leads to the formation of the AD plaques.
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6.1 Reaching the Overall Goal
According to the three aims that we set from the beginning:
a. -- To study and compare conformation assembly for Aβ (1-40) and Aβ (1-42).
b. -- To study the adhesion mechanisms:
c. -- To study and understanding of fibrillar kinetics with model membranes:
We have been able to achieve our goal of elucidating, from the physicochemical point of
view, the implications of the stability and conformations of Aβ in the formation of AD
plaques.
6.2 Aβ (1-40) and Aβ (1-42): Study and Comparison of their Structure and Kinetics
The three Aβ peptide conformations that were considered in this work are:
monomeric, oligomeric and fibrillar. From the AFM data, we were not only able to
directly measure the height and width that corresponds to each of these structures on rigid
(mica) and soft supported (model membrane) substrates, but also, to understand how their
assembly occur with time and how their height/width ratio relates to their kinetic
mechanisms for both peptides.
6.2.1 Aβ (1-40) vs. Aβ (1-42): Comparison of their Structure
The Aβ conformations were prepared on mica and analyzed by AFM. The
samples were incubated as a function of time to observe the following processes:
solubility, stability and dynamics of formation. The evolution of the monomers is shown
below from their initial preparation until 72 hours of incubation in solution. The Aβ40
compared to Aβ42 shows very little absorption with time. In addition, the Aβ40
aggregates slowly into large clusters, with no indication of fibrillar structures being ever
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formed (Table 4). On the contrary, the Aβ42 evolve in two different stages where an
initial effect took place dominated by dissolution of the molecule, and the formation of
thin large fibrils resulted between 9 and 20 hours of incubation.
Table 4. Amyloid-β Peptides 40 and 42, Monomeric Stability Comparison
Peptide
Aβ

0

EVOLUTION TIME [hours]
5

9

20

48

72

40

42

40

42

The scan size for all the images is 2 µm and the height scale is indicated by the bar at the
right hand side of each picture.
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Likewise, oligomeric structures show similar results, where the Aβ40 did not
form fibrillar conformations but clusters. Again, the Aβ42 formed fibrillar structures after
9 hours of incubation (Table 5).
Table 5. Amyloid-β (1-40) and (1-42), Oligomers Formation and Stability
Peptide
Aβ

0

EVOLUTION TIME [hours]
5

9

15

25

> 25

40

42

They did no form fibrils

40

More and longer fibrilliar
conformations were

42

observed

Similarly, scan size for all the images is 2 µm and the height scale varies from each
picture and is indicated by the bar at the right hand side of each picture.
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In the case of fibrilliar structures, the Aβ40 behaves in the same way as for
monomers and oligomers. It was very surprising that almost no fibrils were detected,
although the incubation conditions should have produced them. On the contrary, fibrils
were observed on the Aβ42 after 10 hours of incubation (Table 6).
Table 6. Amyloid-β (1-40) and (1-42), Fibrils Formation and Stability
Peptide
Aβ

>5

EVOLUTION TIME [hours]
10

15

20

48

91

40

42

40

42

Scan size is 2 µm and the variable height scale as indicated on each picture.
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A very interesting result display by the Aβ42 fibrils is that they are intrinsically
different for each structure. In other words, if we look at the scans after 20 hours of
incubation time, the fibrils formed by the oligomers are thicker than that formed by fibrils
or monomeric precursors. In addition, the fibrils formed at longer times seem to be
similar in thickness and shape. This indicates that the preferential structure independently
of the precursor molecules for the Aβ42 is fibril conformation.
In order to compare the evolution of the topography of Aβ structures
quantitatively, we have measured and compared the average ratios between height and
width for each scan, which relates to the affinity of adhesion and surface density. Details
about how these values were calculated are shown in the Appendix F section.
This analysis indicates that two of the three structures undergo a conformation
change at 11 hrs for monomers and 18 hrs of incubation for oligomers for both Aβ40 and
Aβ41, which corresponds to taller fibrils while the thickness remains low. This
conformation change (maximum point) determines a saturation point, where the fibrils
seem to pile up instead of spreading on the substrate. After that, both molecules show that
the fibrils continue spreading onto the surface again. However, for fibril structures the
behavior is very different. The Aβ40 and Aβ42 show opposite performance. In addition,
we observed three interesting stages, one at 4, one at 10 and one at ~48 hours. The one at
4 and 50 hours correspond to a maximum in the Ratio value for Aβ40, but a minimum
values for Aβ42. This is also related to the saturation of the surface as explained above.
At 10 hours both peptides show similar surface density and topography.
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Figure 23. Average Structural Ratio
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6.3. Chemical Characterization of Aβ (1-42) Peptide Conformations
By using the ATR-FTIR technique, we are able to recognize the type of
conformation that each precursor molecule has as a function of time. This study shows
the evolution and dynamics of each chemical structure as a function of incubation
conditions. We were able to distinguish specific structures depending on the IR vibration
modes of the peptides. These structures show well defined processes indicating its
dilution, molecular arrangement, and a steady state (equilibrium).
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Prior to present this analysis; let’s define the ranges of wavenumber used to
classify the existence of determined structure (Table 7).
Table 7. Amide I and II IR Regions for Peptide Molecules
Wavenumber (cm-1)

Structure
Amide I region3
Beta turn

1695-1670 Intermolecular β-structure
1690-1680 Intramolecular β-structure

Random coil

1645-1648

Alpha helix

1657-1648

Beta sheet

1640-1630 Intramolecular β-structure
1625-1610 Intermolecular β-structure
Amide II region4

NH2 deformations

1567 N-H bending (60%);
C-N stretching (40%)

Related to proteins absorption/desorption

centered at 1550

From the FTIR spectra, a deconvolution of the absorbance data was performed to
differentiate from all the structures present in each conformation. The deconvolution
analysis is done with Origin version 6.1. A sample of how this analysis was done is
presented in Figure 24. This corresponds to a sample of fibrillar structures at initial
conditions.

3

Amide I region is between 1600 and 1700 cm-1

4

Amide I region is between 1600 and 1700 cm-1
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Chi^2/DoF
R^2

0.35
-1

1645cm

0.3

Absorbance (a.u.)

0.25
0.2
0.15
0.1

-1

1595cm

-1

1631cm

-1

1558cm

0.05
0
-0.05
1500

1550
1600
1650
-1
Wavenumber (cm )

1700

1750

ID
y0
xc1
w1
A1
xc2
w2
A2
xc3
w3
A3
xc4
w4
A4

9.69E-07
0.99992
Theoretical
Value
0
1645.83
68.00513
22.11764
1631.015
30.44602
3.01095
1595.676
28.66821
0.34583
1558.676
59.33113
2.51592

Error
0
1.31298
0.93894
0.87222
0.46575
1.25849
0.48154
2.49805
5.90861
0.25173
2.86705
2.82359
0.25166

Figure 24. Example of the Deconvolution for Fibrils at Initial Conditions. The
black line represents original data; the red line one represents the outcome of the
deconvolution fitting. The resulting peaks are shown in green
6.3.1. Monomeric Conformation
Figure 25, shows the time evolution spectra for monomeric conformation of Aβ
(1-42) peptides. Spectra were taken from its initial preparation until about 150min of
incubation time. This time interval was chosen based on the AFM analysis. Iit was
observed that fibrils did not form during this time (Table 4). Two particular regions are
observed corresponding to the Amide I and II. The amide I band, between 1600 and
1700 cm-1, is associated with the backbone conformation of the peptide (-Cα=O). Amide
II results from the N-H bending vibration (40-60%) and from the C-N stretching
vibration (18-40%), and is sensitive to the structural configurations.
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0.01
Intra molecular
beta Turns

0.008

0min

Intermolecular
beta turns

Beta Sheet

0.006

-1

(~1630cm )
N-H bending and
C-N stretching

0.004
150min

0.002

0
1750

Alpha helix

1700

1650

1600

1550

-1

Wavenumber(cm )

Figure 25. FTIR Spectra of Amyloid-β (1-42) Peptide Monomeric Precursors
The deconvolution analysis of these peaks based in the assignment from Table 6
appears in the next Table, which the evolution of the various species from initial
conditions until 150 min of incubation time.
The N-H bending and C-N stretching (Not-shown), progressively decrease with
time until they equilibrate after the transition process (>100 min).
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Table 8. Evolution of Individual Conformations for Monomeric Precursors
150

150

135

135
Steady state

120

105

Peptide
rearrangement
& steady state

105

100
Peptide
rearrangement

75
60

Time (min)

Time (min)

120

45

100
75
60
45

30
15

0
0

0.02

0.04

0.06

0.08

0

0.1

0

Integrated absorbance (a.u)

135

120

120

105

105

100

100

Peptide
rearrangement

Time (min)

150

135

60

30

30

15

15

0

0
0.04 0.06 0.08
0.1
0.12
Integrated absorbance (a.u.)

0.4

0.5

0.6

0.14

Peptide
rearrangment

60
45

0.02

0.3

Steady state

75

45

0

0.2

Intramolecular β-turns: Notice a decrease
in the amount of this type of structure from
0 to 30min, which is associated with the
dilution zone. > 45 min, the protein steadily
reaches a stable concentration. The amount
of β turns decays during monomeric
evolution

150

75

0.1

Integrated absorbance (a.u.)

Intermolecular β-turns: Three stages can
be seen: 1) dilution process, from 0-30
min., 2) peptide rearrangement, after 45
minutes there is a steady increase of this
structure, and 3) equilibrium process, from
100 min to 150

Time (min)

Dilution

30

Dilution

15

Dilution
0

0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4
Integrated absorbance (a.u.)

α-helix structure: After dissolution stage, β sheets structures: Increase continuously
these structures are suddenly visible. They until they reaches an equilibrium state (>
appear in the transition process, and 105 min). The sudden shift corresponds to
disappear again coinciding with the the lost of α-helix structure
formation of β sheets
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6.3.2. Oligomeric Conformations
The oligomeric precursors were studied from initial conditions until after 9 hours
(Figure 26). Remember that between 10 to 15 hours, the oligomers started producing
fibrillar conformations as shown Table 5. Overall, the IR spectra clearly demonstrated
that the oligomeric species are centered in the Amide I (1685-1670 cm-1). This is region
was deconvoluted into two regions that correspond to β turns both inter- and intramolecular (Table 9). In addition, there is a well defined region that can be assigned to
Amide II (1567-1500 cm-1), and corresponds to the absorption process of oligomeric
structures onto a substrate. Similarly to the monomeric species, these molecules undergo
a dissolution process initially (0-3 hours). The absorption process accelerates with time
until it reaches equilibrium from about 3 hours until after 9 hours of incubation.
0.3
540min

Absorbance (a.u.)

0.25

180min
120min
60min

0.2

0min

0.15

0.1

0.05

0
1750

1700

1650

1600

1550

1500

-1

Wavenumber (cm )

Figure 26. Structures Evolution with Time of Oligomeric Precursors of Aβ (1-42)
Peptides
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Table 9. Evolution of Individual Conformations for Oligomeric Precursors
540

540

480

480
420

Steady state

360

Time (min)

Time (min)

420

300
240

Steady state

360
300
240
180

180

Dilution and peptide
rearrangement

120

120

60

60

0

0

0

2

4
6
8
10
12
-1
Integrated absorbance (cm )

Dilution and peptide
rearrangement

0

14

2

4

6

8

-1

10

Integrated absorbance (cm )

Intermolecular β-turns: Two stages can Intramolecular β turns: Similar behavior
be seen: 1) dilution process, which also as for intermolecular β turns. It is amazing
includes the rearrangement of the peptide how both structures follow parallel paths
molecules and, 2) steady state equilibrium
540

540

480

480

Steady state

420

360
Time (min)

Time (min)

420

300
240
180
Dilution and
peptide
rearrangement

120
60

Steady state

360
300
240
180
120

0

Dilution and
peptide
rearrangement

60

0

5

10

15

0

-1

Integrated Absorbance (cm )

0

5

10

15

20

-1

Integrated absorbance (cm )

NH2 deformations: Taken from the Amide
II region, two stages are seen as function of
time, where they follow similar formation
and transition paths

Absorption/desorption process: It is clear
that oligomeric species deposit on the
substrate surface. Very good agreement
with AFM data (Table 5).

60

6.3.3. Fibril Conformation
The time evolution of fibrillar species is a little bit more complicated than for
that for other configurations, because they show a longer dissolution processes, a
transition process, an a state where some chemical conformation reach equilibrium
but other molecules keep changing and do not reach a constant dynamics. The IR
spectra show a very interesting behavior. First, the regions assigned to β-sheet decays
with time, where as the Amide II region decreases and reaches an equilibrium state.
This indicates two processes, one, the β sheets are evolving and are been redistributed
or transformed into other chemical conformations. Second, the fibrils form and
absorbs onto the surface in the first 3 hours (Table 10). After that, they rearrange or
chemical alter while being attached to the substrate. This is a very important finding
since indicates that the fibrils may form in solution, but they form, react and
transform even after being absorb on a surface (Figure 27).

Figure 27. Time Evolution Spectra of Fibril Structures of Aβ (1-42)
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Table 10. Evolution of Individual Conformations for Fibrillar Precursors
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The N-H bending and C-N stretching behavior shows a constant dynamics that
varies with respect to the other species. The interactions come and go according to the
dissolution and transition processes.
We found an astonishing behavior when we determine the integrated absorbance
for each structure in time. The fibrils and oligomers go from a maximum energetic level,
when they just started dissolving, to a lower region when formation/absorption
mechanisms are competing with each other. This change of energy takes place in the first
three hours of formation. On the other hand, monomeric precursors do not change with
time but after 3 hours, they start degenerating.

Figure 28. Comparison of Surface Dynamics for the Three Peptide Structures: Integrated
Absorbance Evolution with Time
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6.4. Membrane Construction
One of the goals of this research is to study the interactions of fibril structures
with model membranes. The membranes are prepared by using L-B deposition techniques
on rigid and soft supported surfaces. The lipid membranes were constructed with DSPE
and its surface stability was studied as explained next.
At the air/water interface, we observed the behavior of DSPE layers as a function
of lipid concentration. We found that the optimum concentration for the deposition of the
layers was 2.45mg/mL, and the optimum surface pressure should be between 20-40
mN/m. Other concentrations resulted on weaker layers or limited the areas to perform the
transfer of the lipid layers to a substrate (Figure 29).
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Figure 29. Surface Tension of DSPE as a Function of Lipid Concentration. Low
concentrations resulted in low ordering, and high concentrations resulted in rigid and
fragile layers
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Once

the

optimum

concentration

was

determined,

we

performed

loading/unloading cycle to test the response of the layer to dynamic changes. We
observed that this concentration also promote stable layers (Figure 30).
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Figure 30. Loading/Unloading Cycle for DSPE at 2.45mg/mL and 30mN/m
The layers were transferred to the PEG/silica substrates with a transferred ration
of 99.94%. The pressure-area (π-A) isotherm is shown in Figure 31 for our system. Once
the layers were deposited we look at them using AFM in lipid rich-aqueous solutions.
The images of the membranes show a layer that has high mobility (Figure 32a). This
layer was then exposed to a very high concentration of fibrillar solution and then scanned
in situ. We found that initially, some fibril structures deposited on the surface of the
membrane (Figure 32b). However, they did not stay absorbed for very long. We believe
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that the mobility of the layers influence the absorption mechanism to which this fibrils
attach to surfaces, since the fibrils did not appear in further scans of the model membrane
surface (Figure 32c).
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Figure 31. Deposition and Transfer of the Lipid DSPE Bilayer onto the PEG/silica
Substrates to Create the Model Membranes

Figure 32. Interacting Mechanisms Between Lipid Bilayers and
Aβ (1-42) Peptide Fibrils Using AFM Liquid Imaging. (a) 10 by 10 µm scan of the model
membrane surface as deposited, (b) Scan after fibrils have been added to the membrane,
and (c) Scan soon after fibril exposure. The fibril structures refused to adhere on the
surface possibly owing to the surface mobility of the soft-supported membranes
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One of the questions is if the fibrils really are influenced by the mobility of the
membrane. Let’s look at the section scan from Figure 32b (Figure 33) to analyze such
behavior. The height of the fibrils corresponds to 6nm, which happens to match the
height of the fibers adhered to rigid supports also detected by AFM (Table 4, 5, and 6).
Therefore, it is reasonable to assume that the fibers indeed adhere to cell membranes, but
the surface mobility makes such adhesion very weak. This is an important finding since
the implications of finding the molecular mechanism of Aβ peptides to membranes may
lead us to determine the processes that control fibril adhesion and plaque formation. That
is, these findings might lead us in a direction to find release mechanisms that will prevent
or stop adhesion all together.

Figure 33. Section Profile of Biomimetic Membrane Surfaces in Contact with Fibrils.
The height of the fibrils average 6nm, which corresponds to the values report elsewhere
and reported early in this chapter (See Table 6) [23, 26]
67

Chapter Seven
Conclusions and Future Work
7.1 General Findings and Conclusions
This project had a very well defined goal from the beginning, which was to study,
control and determine the implications of having three different structures of the two
peptides that are most influential in AD brain’s dysfunction, the Aβ-40 and Aβ-42. We
were able to establish the procedures to prepare stable and reproducible configurations of
Aβ peptides, so that we could study their interactions with biomimetic membranes.
The most important findings in terms of amyloid beta peptide adhesion to surfaces
are as follow:
a. There is a distinct trend between the Aβ1-40 and Aβ1-42 in terms of adhesion to
rigid surfaces. Aβ1-40 exhibits a poor adhesion to mica, whereas Aβ1-42 shows a
strong adhesion to rigid supports. This difference in adhesion behavior may be
correlated to the toxicity and propensity to form longer aggregates that ultimately
form fibrils and plaques in normal conditions, since our ATR data shows that
fibrillar configurations have a very complex adhesion mechanism to surfaces.
b. The Aβ1-40 show to be more stable in terms of aggregation. In most cases, this
peptide did not form fibrillar structures even though the conditions to form them
were heavily induced.
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c. There is a strong correlation between data from the two surface analytical
techniques used in this project. AFM and FTIR data show the effect of a dilution
process. This mechanism takes place in the first 30 min. of precursor incubation.
However, it has a great impact in the evolving time to achieve equilibrium state.
There was a transition zone where the structures of the peptides rearrange and
most of the conformations decrease or increase at this time (between 1-3 hours).
d. In the case of the Aβ1-42, the formation of bigger aggregates into fibrillar
configurations started to take place > 9 hours of incubation for most cases.
e. We were able to correlate the individual configurations of these molecules with
kinetics and dynamics of adhesion.
f. We were able to control fibril formation or fibrilogenesis, since it was shown that
nonfibrillar assemblies were maintained and studied in vitro.
g. The adhesion process of fibrillar structures and aggregates is very complex and
depends on the preparation conditions and the affinity of the peptide to surface
structure.
h. We were able to distinguish between intermolecular β turn structures (1695-1670
cm-1), intramolecular β turn structures (1690-1680 cm-1). Typically, these
structures are not seen in protein conformation studies.
i. AFM studies illustrate how oligomeric and monomeric configurations of Aβ-40
and 42 follow a general trend in terms of their ratio of height and width. That is,
they absorbed onto themselves instead of the substrate until saturation is reached.
Only after that the peptide will continue absorbing onto the substrate.
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j. For fibril configurations, the ratio of height/width of Aβ-40 and Aβ-42 follows an
inversely proportional trend.
k. Biomimetic membranes can be built onto PEG layers to mimic real surface
mobility.
l. The interactions between biomimetic membranes and fibrils show that the fibrils
initially absorb, but that the absorption is very weak. This may be a function of
surface flexibility and softness created by the PEG underneath layer.
m. By comparing the adhesion behavior of the fibril to the mica with the adhesion
behavior to biomimetic membranes, we concluded that the rigidity of the substrate
indeed is plays an important role in the adhesion mechanisms of the fibrils.
n. These findings led us to hypothesize that normal fibrils attach to real cell
membranes because they have lost mobility somehow. It has been discussed that
cholesterol may have an important role in AD plaque formation. This hypothesis
agrees with the literature studies were Statins have helped to reduce the effects of
AD symptoms [31-33].
7.2 Final Remarks and Future Work
a. This work has advanced our ability to master a systematic way to prepare the
three different conformations of Aβ peptides that may play an important role in
AD plaque formation.
b. If these three conformations may influence plaque formation, we may be able to
understand the molecular mechanisms associated with their adhesion, surface
kinetics and assembly processes by using the Surface Forces Apparatus and the
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ATR-FTIR technique concurrently (IR-SFA).
c. Further investigation developing essays with the two peptides together is needed
to elucidate why only Aβ42 segments cause adhesion, and how they influence
Aβ40 peptide dynamic processes.
d. Additional studies to corroborate our initial findings on the effect of substrate
mobility will be performed. For instance, we would like to vary systematically the
rigidity of model membranes by introducing cholesterol in their structure.
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Appendix A. Milestones Toward Formulating and Testing the Aβ Hypothesis of AD[9]
1892-1907
1920-40
1970-86
1987-88

1989-99

1990-92
1992-93
1992-93
1991-97
1995-2000

1998-99
1999-2000

1999-2000
1995-2000

Lesions associated with Alzheimer’s neurodegeneration described and categorized
(Alzheimer 1907; Blocq and Marinesco 1892; Redlich 1898)
Amyloid plaques and perivascular deposits described and proposed to adversely
affect cerebral function (Divry 1927; Scholz 1938)
Isolation (Nikaido et al. 1971), amino acid composition (Allsop et al. 1983; Roher
et al. 1986, Selkoe et al. 1986) and N-terminal sequences of perivascular (Glenner
and Wong 1984) and parenchymal plaque Aβ (Masters et al. 1985)
Amyloid precursor protein (APP) gene cloned, located on chromosome 21 and Aβ
recognized as putative proteolytic product (Kang et al. 1987; Tanzi et al. 1987,
1988; Goldgaber et al. 1987; Robakis et al. 1987; Kitaguchi et al. 1988; Ponte et
al. 1988)
Toxicity of Aβ in cell culture (Whitson et al. 1989; Yankner et al. 1989),
mediated by oxidative processes (Behl et al. 1992, 1994; Dyrks et al. 1992;
Butterfield et al. 1994) and metals (Bush et al. 1994; Schubert and Chevion 1995;
Huang et al. 1999; Cherny et al. 1999)
Mutations in proximity to Aβ secretase sites cause AD (Levy et al. 1990;
Chartier- Harlin et al. 1991; Goate et al. 1991; Murrell et al. 1991; Citron et al.
1992; Hendriks et al. 1992) and confirm centrality of Aβ hypothesis
Aβ and p3 identified as definite proteolytic products from APP (Seubert et al.
1992, 1993; Shoji et al. 1992; Busciglio et al. 1993)
ApoE identified as an Aβ-interacting protein (Wisniewki and Frangione 1992;
Strittmatter et al. 1993) and its alleles identified as genetic risk factors in sporadic
forms of AD (Coder et al. 1993)
Transgenic mouse models of Aβ deposition (Quon et al. 1991; Borchelt et al.
1997; Sturchler-Pierrat et al. 1997; Games et al. 1995; Hsiao et al. 1996)
Presenilins recognized as major components in the amyloidogenic pathway
(Levy-Lahad 1995; Borchelt et al. 1996; Sherrington et al. 1995; Rogaev et al.
1995; Scheuner et al. 1996), probably acting as γ-secretases (Ray et al. 1999;
Capell et al. 2000; Kimberly et al. 2000; Jacobsen et al 1999; Octave et al. 2000;
De Strooper et al. 1998, 1999; Wolfe et al. 1999a, b; Steiner et al. 1999.
α-secretases identified (Buxbaum et al. 1998; Lammich et al. 1999)
Major Aβ degradative and clearance pathway identified (Iwata et al . 2000; Qiu et
al. 1999; Vekrellis et al. 2000) and improved clearance of Aβ from the brain by
immunization with Aβ (Schenk et al. 1999)
β-secretases identified (Vassar et al. 1999; Yan et al. 1999; Sinha et al. 1999; Lin
et al. 2000; Hussain et al. 1999)
First rational anti-amyloid therapeutic strategies (Higaki et al. 1995) and
commencement of early phase human trials (Bristol Myers Squibb, Elan
Pharmaceuticals, Prana Biotechnology)
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Appendix B. The 20 Protein Amino Acids
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Appendix C. Chemical Forces and their Relative Strengths and Distances

Force
Van der Waals
interactions

Hydrogen bonds
Ionic bonds

Strength
(kJ/mol)
0.4 - 4.0

Distance
(nm)
0.2

12 – 30

0.3

20

0.25

Description
Strength depends on the relative size of the atoms or
molecules and the distance between them. The size factor
determines the area of contact between two molecules: the
greater the area, the stronger the interaction. Attractive force
is inversely proportional to the sixth power of the distance, r,
separating two atoms or molecules: F ≈ 1/r6.
Relative strength is proportional to the polarity of the H bond
donor and H bond acceptor. More polar atoms form stronger
H bonds.
Strength also depends on the relative polarity of the
interacting charged species. Some ionic bonds are also H
+

−

bonds: − NH 3 ... OOC −
Hydrophobic
interactions

< 40

-

Force is a complex phenomenon determined by the degree to
which the structure of water is disordered as discrete
hydrophobic molecules or molecular regions coalesce.
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Appendix D. Infrared Spectra
Appendix D.1. Characteristic Infrared Bands of Proteins [28]
Amino acid Wavenumber (cm-1)
Assignment
A
3300
N-H stretching in resonance with overtone
B
3110
(2 x amide II)
I
1653
80% C=O stretching; 10% C-N stretching; 10% NH bending
II
1567
60% N-H bending; 40% C-N stretching
III
1299
30% C-N stretching; 30% N-H bending; 10% C=O
stretching; 10% O=C-N bending; 20% other
IV
627
40% O=C bending; 60% other
V
725
N-H bending
VI
600
C=O bending
VII
200
C-N torsion

Appendix D.2. Characteristic Infrared Bands of Amino Acid Side Chains [28]
Amino acid
Alanine
Valine
Leucine
Serine
Aspartic acid
Glutamic acid

Wavenumber (cm-1)
1465
1450
1375
1350-1250
1720
1560
1415

Asparagine
Glutamine
Lysine

1650
1615
1640-1610,1550-1485
1160,1100

Phenylalanine
Tyrosine
Arginine

1602,1450,760,700
1600,1450
1608,1586

Assignment
CH2 bending
CH3 asymmetric bending
CH3 symmetric bending
OH bending
C=O stretching
CO −2 asymmetric stretching
CO −2 symmetric stretching
C=O stretching
NH2 bending
NH 3+ bending
NH 3+ rocking
Benzene ring vibrations
Benzene ring vibrations
Benzene ring vibrations
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Appendix E. Material Safety Data Sheets.
Appendix E.1. Aβ1-40

81

Appendix E.1. (Continued)
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Appendix E.1. (Continued)
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Appendix E.2. Aβ1-42
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Appendix E.2. (Continued)
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Appendix E.2. (Continued)
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Appendix F. One Example on AFM Data Processing
I. Amyloid β (1-40) Monomer 0 hours (File: ab40-monomer-0h-2um)

B
A
C

B

C

A

a.

Group A:

H1
H2

W2

W1
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b.

Group B:

H1
H2

W2

W1

c.

Group C:

H1

W1
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Appendix G. Transferred Area Calculation
Transferred Rate Area (ATR) :
ATR =

total transferred area to the wafers and tweezer(calculated)
* 100%
area transferred (read from data)

From Figure 31, one can see the transferred area, this is
Transferred area= (the initial area at which 30mN/m is reach –
final area after deposition)
Hence,
Transferred area= 230.37 cm2 –177.32 cm2 = 53.05 cm2
Now the wafer’s dimension were

1.912cm

with a thickness of .05 cm

1.912cm
The total area for the wafer is
Awafer = 2*(1.912cm)2 + (0.05cm*1.912cm)*4 = 7.7cm2
The deposition was done to two wafers at the same time with the same dimension,
therefore the total area transfer to the wafer twice because we are building a bilayer, is;
Atransfer to the wafer s (bilayer) = 7.7cm2 * 4 = 30.8cm2
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Appendix G. (Continued)

Next we need to calculate the area transferred to the tweezers use to hold the wafers, and
the dimensions were:
1

1.31 cm

2

1.31 cm

1.896cm

1.189 cm

Thickness= 0.5

Thickness= 0.2

Area of 1:
(1.31 cm * 1.896 cm) * 2 = 4.97 cm2

A1 =

(0.5 cm * 1.31 cm)* 2 = 1.31 cm2

+

(0.5cm * 1.896) = 0.948 cm2

Total area 1: A1 = 7.23 cm2
Area of 2:
(1.31 cm * 1.189 cm) * 2 = 3.12 cm2

A2 =
+

(0.2 cm * 1.31 cm)* 2 = 0.524cm2
(0.2cm * 1.189) = 0.2378 cm2

Total area 1:

A2 = 3.88 cm2
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Appendix G. (Continued)
Total area transferred to the tweezers= 2* A1 + A2 = 22.22cm2
Total transferred area is:
Area transferred to the wafers + area transferred to the tweezers=
Atotal transferred = 30.8 cm2 + 22.22cm2 = 53.02 cm2
Hence the transferred rate is:
ATR =

52.02 cm 2
* 100% = 99.94%
52.03 cm 2
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